What is a stock summary page? Click here for an overview.
Business Description
Nagaileben Co Ltd
ISIN : JP3647000003
Share Class Description:
TSE:7447: Ordinary SharesDescription
Nagaileben Co Ltd manufactures and sells medical clothing and shoes for doctors, dentists, pharmacists, nursing staff, patients, and care workers. Nearly all the company's sales are in Japan, with more than half of total sales in east Japan and the remaining Japanese sales in central Japan and west Japan. The company's six item segments are healthcare wear, surgery wear, doctor wear, utility wear, patient wear, and shoes. Healthcare wear accounts for more than half of total company revenue. Doctors' wear, patient wear, and surgery wear constitute most of the remaining revenue. The company manufactures its products in Japan and Indonesia.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.93 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 13.4 | |||||
| Beneish M-Score | -2.46 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.1 | |||||
| 3-Year EBITDA Growth Rate | -7.2 | |||||
| 3-Year EPS without NRI Growth Rate | -7.3 | |||||
| 3-Year FCF Growth Rate | -19.5 | |||||
| 3-Year Book Growth Rate | 2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 6.09 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 5.01 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.76 | |||||
| 9-Day RSI | 55.43 | |||||
| 14-Day RSI | 53.3 | |||||
| 3-1 Month Momentum % | -1.77 | |||||
| 6-1 Month Momentum % | -14.16 | |||||
| 12-1 Month Momentum % | -16.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 15.94 | |||||
| Quick Ratio | 12.73 | |||||
| Cash Ratio | 10.35 | |||||
| Days Inventory | 253.38 | |||||
| Days Sales Outstanding | 62.45 | |||||
| Days Payable | 48.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.02 | |||||
| Dividend Payout Ratio | 0.69 | |||||
| Forward Dividend Yield % | 6.03 | |||||
| 5-Year Yield-on-Cost % | 3.06 | |||||
| 3-Year Average Share Buyback Ratio | 1.4 | |||||
| Shareholder Yield % | 3.06 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 41.22 | |||||
| Operating Margin % | 23.1 | |||||
| Net Margin % | 16.34 | |||||
| FCF Margin % | 12.56 | |||||
| ROE % | 6.61 | |||||
| ROA % | 6.08 | |||||
| ROIC % | 14.19 | |||||
| 3-Year ROIIC % | -40.69 | |||||
| ROC (Joel Greenblatt) % | 22.92 | |||||
| ROCE % | 9.14 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 22.76 | |||||
| Forward PE Ratio | 21.39 | |||||
| PE Ratio without NRI | 22.76 | |||||
| Shiller PE Ratio | 17.4 | |||||
| PS Ratio | 3.71 | |||||
| PB Ratio | 1.51 | |||||
| Price-to-Tangible-Book | 1.52 | |||||
| Price-to-Free-Cash-Flow | 29.85 | |||||
| Price-to-Operating-Cash-Flow | 27.65 | |||||
| EV-to-EBIT | 9.8 | |||||
| EV-to-EBITDA | 9.47 | |||||
| EV-to-Revenue | 2.26 | |||||
| EV-to-FCF | 17.62 | |||||
| Price-to-GF-Value | 0.92 | |||||
| Price-to-Projected-FCF | 1.01 | |||||
| Price-to-Median-PS-Value | 0.81 | |||||
| Price-to-Graham-Number | 1.24 | |||||
| Price-to-Net-Current-Asset-Value | 1.9 | |||||
| Price-to-Net-Cash | 3.1 | |||||
| Earnings Yield (Greenblatt) % | 10.2 | |||||
| FCF Yield % | 3.46 | |||||
| Forward Rate of Return (Yacktman) % | -3.52 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nagaileben Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 16,863.805 | ||
| EPS (TTM) (円) | 87.39 | ||
| Beta | 0.49 | ||
| 3-Year Sharpe Ratio | 0.02 | ||
| 3-Year Sortino Ratio | 0.03 | ||
| Volatility % | 28.94 | ||
| 14-Day RSI | 53.3 | ||
| 14-Day ATR (円) | 66.359942 | ||
| 20-Day SMA (円) | 1960.75 | ||
| 12-1 Month Momentum % | -16.39 | ||
| 52-Week Range (円) | 1725 - 2702 | ||
| Shares Outstanding (Mil) | 30.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nagaileben Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nagaileben Co Ltd Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nagaileben Co Ltd Frequently Asked Questions
What is Nagaileben Co Ltd(TSE:7447)'s stock price today?
The current price of TSE:7447 is 円1989.00. The 52 week high of TSE:7447 is 円2702.00 and 52 week low is 円1725.00.
When is next earnings date of Nagaileben Co Ltd(TSE:7447)?
The next earnings date of Nagaileben Co Ltd(TSE:7447) is .
Does Nagaileben Co Ltd(TSE:7447) pay dividends? If so, how much?
The Dividend Yield %  of Nagaileben Co Ltd(TSE:7447) is 3.02% (As of Today), Highest Dividend Payout Ratio of Nagaileben Co Ltd(TSE:7447) was 0.69. The lowest was 0.51. And the median was 0.55. The  Forward Dividend Yield % of Nagaileben Co Ltd(TSE:7447) is 6.03%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers